A kind of preparation method of 3-methyl-4-oxo-4-(p-amino)phenylbutyric acid
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- ASTATECH CHENGDU BIOPHARM CORP
- Publication Date
- 2016-05-11
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to a preparation method of an intermediate of levosimendan, a medicine for enhancing myocardial contractility, and in particular to a preparation method of 3-methyl-4-oxo-4-(p-amino)phenylbutyric acid. Background technique
[0002] Levosimendan is a calcium sensitizer drug for enhancing myocardial contractility developed by Orion, Finland, and is the first drug of this type to be marketed. First launched in Sweden in October 2000, it is used to treat various acute and refractory heart failure diseases.
[0003]
[0004] The mechanism of action of levosimendan is mainly by increasing the sensitivity of cardiac contractile proteins to calcium ions and opening the ATPase-sensitive potassium ion channels on the cell membrane, increasing the myocardial contractility while dilating peripheral blood vessels and coronary arteries, and reducing the anterior and posterior cardiac tension. The load can quickly improve the symptoms of pat...